Skip to main content
. 2010 Nov 4;15(11):1135–1146. doi: 10.1634/theoncologist.2010-0078

Table 3.

Study design and efficacy for selected randomized trials of novel agents in renal cell carcinoma

graphic file with name onc01110-0696-t03.jpg

aTotal population.

bStarting dose.

Abbreviations: bid, twice daily; IFN, interferon; MIU, million international units; NR, none reported; q2w, every 2 weeks; qd, once daily; qw, every week; RCC, renal cell carcinoma; tiw, three times weekly.